Black Rock Inc. Arcturus Therapeutics Holdings Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Black Rock Inc. holds 2,649,838 shares of ARCT stock, worth $58 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,649,838
Previous 2,743,002
3.4%
Holding current value
$58 Million
Previous $92.6 Million
30.34%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ARCT
# of Institutions
171Shares Held
25.9MCall Options Held
321KPut Options Held
136K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$103 Million0.12% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.83MShares$40.1 Million0.02% of portfolio
-
Nikko Asset Management Americas, Inc.1.83MShares$40 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$39.6 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.72MShares$37.5 Million0.18% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $581M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...